High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma

Over the years, molecular subtypes based on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2) status have been observed to effectively guide decision-making for the optimal treatment of patients with breast carcinoma (BRCA). However, despite thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Gaoda, Xu, Cheng, Zeng, Kai, Zhou, Tianhao, Zang, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806988/
https://www.ncbi.nlm.nih.gov/pubmed/34635011
http://dx.doi.org/10.1080/21655979.2021.1990673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806988/
https://www.ncbi.nlm.nih.gov/pubmed/34635011
http://dx.doi.org/10.1080/21655979.2021.1990673

Ejemplares similares